Kricheldorff J, Göke K, Kiebs M, Kasten FH, Herrmann CS, Witt K, Hurlemann R (2022) Evidence of neuroplastic changes after transcranial magnetic, electric and deep brain stimulation. Brain Sciences (in press) [IF 3.3*]
Schröder R, Faiola E, Urquijo MF, Bey K, Meyhöfer I, Steffens M, Kasparbauer AM, Ruef A, Högenauer H, Hurlemann R, Kambeitz J, Philipsen A, Wagner M, Koutsouleris N, Ettinger U (2022) Neural correlates of smooth pursuit eye movements in schizotypy and recent onset psychosis: a multivariate pattern classification approach. Schizophrenia Bulletin Open (in press) [IF n.a.]
Wölwer W, Frommann N, Lowe A, Kamp D, Weide K, Bechdolf A, Brockhaus-Dumke A, Hurlemann R, Muthesius A, Klingberg S, Hellmich M, Schmied S, Meyer-Lindenberg A; ISST study group (2022) Efficacy of integrated social cognitive remediation vs. neurocognitive remediation in improving functional outcome in schizophrenia: Concept and design of a multicenter, single-blind RCT (the ISST study). Frontiers in Psychiatry 13: 909370 [IF 5.4*]
Haier J, Beller J, Adorjan K, Bleich S, De Greck M, Griesinger F, Hein A, Hurlemann R, Mees ST, Philipsen A, Rohde G, Schilling G, Trautmann K, Combs SE, Geyer S, Schäfers J (2022) Decision conflicts in clinical care during COVID-19: A patient perspective. Healthcare (Basel) 10: 1019 [IF 3.1*]
König A, Müller P, Tröger J, Lindsay H, Alexandersson J, Hinze J, Riemenschneider M, Postin D, Ettore E, Lecomte A, Musiol M, Amblard M, Bremond F, Balazia M, Hurlemann R (2022) Multimodal phenotyping of psychiatric disorders from social interaction: Protocol of a clinical multicenter prospective study. Personalized Medicine in Psychiatry 33: 100094 [IF n.a.]
Lehmann M, Neumann C, Wasserthal S, Delis A, Schultz J, Hurlemann R, Ettinger U (2022) Ketamine increases fronto-posterior functional connectivity during meta-perceptual confidence ratings. Behavioural Brain Research 430: 113925 [IF 3.4*]
Morr M, Liu X, Hurlemann R, Becker B, Scheele D (2022) Chronic loneliness: Neurocognitive mechanisms and interventions. Psychotherapy & Psychosomatics 2: 1 - 11 [IF 26.0*]
Morr M, Noell J, Sassin D, Daniels J, Philipsen A, Becker B, Stoffel-Wagner B, Hurlemann R, Scheele D (2022) Lonely in the dark: Trauma memory and sex-specific dysregulation of amygdala reactivity to fear signals. Advanced Science 9: e2105336 [IF 17.5*]
Saporta N, Scheele D, Lieberz J‚ Nevat M, Kanterman A, Hurlemann R, Shamay-Tsoory SG (2022) Altered activation in the action observation system during synchronization in high loneliness individuals. Cerebral Cortex (in press) [IF 4,9*]
Lieberz J‚ Shamay-Tsoory SG, Saporta N, Kanterman A, Gorni J, Esser T, Kuskova E, Schultz J, Hurlemann R, Scheele D (2022) Behavioral and neural dissociation of social anxiety and loneliness. The Journal of Neuroscience 42: 2570 - 2583 [IF 6,7*]
Saporta N, Peled-Avron L, Scheele D, Lieberz J‚ Hurlemann R, Shamay-Tsoory SG (2022) Touched by loneliness – How loneliness impacts the response to observed human touch: a tDCS study. Social Cognitive & Affective Neuroscience (SCAN) 17: 142 - 150 [IF 4.2*]
Hebel T, Grözinger M, Landgrebe M, Padberg F, Schecklmann M, Schlaepfer T, Schönfeldt-Lecuona C, Ullrich H, Zwanzger P, Langguth B; And the DGHP Consensus Group, Bajbouj M, Bewernick B, Brinkmann K, Cordes J, Di Pauli J, Eichhammer P, Freundlieb N, Hajak G, Höppner-Buchmann J, Hurlemann R, Kamp D, Kayser S, Kis B, Kreuzer PM, Kuhn J, Lammers M, Lugmayer B, Mielacher C, Nickl-Jockschat T, Nunhofer C, Palm U, Poeppl TB, Polak T, Sakreida K, Sartorius A, Silberbauer C, Zilles-Wegner D (2022) Evidence and expert consensus based German guidelines for the use of repetitive transcranial magnetic stimulation in depression. The World Journal of Biological Psychiatry (in press) [IF 3.4*]
Saporta N, Scheele D, Hurlemann R, Lieberz J, Stuhr-Wulff F, Shamay-Tsoory SG (2021) Opposing association of situational and chronic loneliness with interpersonal distance. Brain Sciences 11: 1135 [IF 3.3]
Lieberz J, Shamay-Tsoory SG, Saporta N, Esser T, Kuskova E, Stoffel-Wagner B, Hurlemann R, Scheele D (2021) Loneliness and the social brain: how perceived social isolation impairs human interactions. Advanced Science 8: e2102076 [IF 17.5]
Doppelhofer LM, Hurlemann R, Bach DR, Korn CW (2021) Social motives in a patient with bilateral selective amygdala lesions: Shift in prosocial motivation but not in social value orientation. Neuropsychologia 162: 108016 [IF 3.1]
Morr M, Lieberz J, Dobbelstein M, Philipsen A, Hurlemann R, Scheele D (2021) Insula reactivity mediates subjective isolation stress in alexithymia. Scientific Reports 11:15326 [IF 5.0]
Fassbender K, Bey K, Lippold JV, Aslan B, Hurlemann R, Ettinger U (2021) GABAergic modulation of performance in response inhibition and interference control tasks. Journal of Psychopharmacology 35: 1496 - 1509 [IF 4.6]
Lehmann M, Neumann C, Wasserthal S, Schultz J, Delis A, Trautner P, Hurlemann R, Ettinger U (2021) Effects of ketamine on brain function during metacognition of episodic memory. Neuroscience of Consciousness 7: niaa028 [IF n.a.]
Marsh N, Scheele D, Posten D, Onken M, Hurlemann R (2021) Eye-tracking reveals a role of oxytocin in attention allocation towards familiar faces. Frontiers in Endocrinology 12: 629760 [IF 6.0]
Coenjaerts M, Pape F, Santoso V, Grau F, Stoffel-Wagner B, Philipsen A, Schultz J, Hurlemann R, Scheele D (2021) Sex differences in economic decision-making: exogenous estradiol has opposing effects on fairness framing in women and men. European Neuropsychopharmacology 50: 46 - 54 [IF 5.4]
Marvar P, Andero-Gali R, Hurlemann R, Lago TR, Zelikowsky M, Dabrowska J (2021) Limbic neuropeptidergic modulators of emotion and their therapeutic potential for anxiety and post-traumatic stress disorder. The Journal of Neuroscience 41: 901 - 910 [IF 6.7]
Bey K, Lippold JV, Aslan B, Hurlemann R, Ettinger U (2021) Effects of lorazepam on prosaccades and saccadic adaptation. Journal of Psychopharmacology 35: 91 - 99 [IF 4.6]
Gellner AK, Voelter J, Schmidt U, Beins EC, Stein V, Philipsen A, Hurlemann R (2021) Molecular and neurocircuitry mechanisms of social avoidance. Cellular & Molecular Life Sciences (CMLS) 78: 1163 - 1189 [IF 9.2]
Marsh N, Marsh AA, Lee MR, Hurlemann R (2021) Oxytocin and the neurobiology of prosocial behavior. The Neuroscientist 27: 604 - 619 [IF 7.2]
Grobe-Einsler M, Vogt IR, Schaprian T, Hurlemann R, Klockgether T, Kaut O (2020) Effects of rivastigmine in patients with spinocerebellar ataxia type 3 (SCA3) - a case series of five patients. Neurodegenerative Diseases 20: 104 - 109 [IF 3.0]
Mielacher C, Schultz J, Kiebs M, Dellert T, Metzner A, Graute L, Högenauer H, Maier W, Lamm C, Hurlemann R (2020) Individualized theta-burst stimulation modulates hippocampal activity and connectivity in patients with major depressive disorder. Personalized Medicine in Psychiatry 23: 100066 [IF n.a.]
Maier A, Heinen-Ludwig L, Güntürkün O, Hurlemann R, Scheele D (2020) Childhood maltreatment alters the neural processing of chemosensory stress signals. Frontiers in Psychiatry 11: 783 [IF 4.2]
Lippold JV, Ettinger U, Hurlemann R, Corr PJ, Reuter M, Perkins AM (2020) Differentiating anxiety from fear: An experimental-pharmacological approach. Personality Neuroscience 3: e6 [IF n.a.]
Kinfe TM, Stadlbauer A, Winder K, Hurlemann R, Buchfelder M (2020) Incisionless MR-guided focused ultrasound: Technical considerations and current therapeutic approaches in psychiatric disorders. Expert Review of Neurotherapeutics 20: 687 - 696 [IF 4.6]
Kreuder AK, Scheele D, Schultz J, Hennig J, Marsh N, Dellert T, Ettinger U, Philipsen A, Babasiz M, Herscheid A, Remmersmann L, Stirnberg R, Stöcker T, Hurlemann R (2020) Common and dissociable effects of oxytocin and lorazepam on the neurocircuitry of fear – A randomized clinical trial. Proceedings of the National Academy of Sciences USA (PNAS) 117: 11781 - 11787 [IF 11.2]
Kaut O, Mielacher C, Hurlemann R, Wüllner U (2020) Resting-state fMRI reveals increased functional connectivity in the cerebellum but decreased functional connectivity of the caudate nucleus in Parkinson's disease. Neurological Research 42: 62 - 67 [IF 2.5]
Lieberz J, Scheele D, Spengler FB, Matheisen T, Schneider L, Stoffel-Wagner B, Kinfe TM, Hurlemann R (2020) Kinetics of oxytocin effects on amygdala and striatal reactivity vary between women and men. Neuropsychopharmacology 45: 1134 - 1140 [IF 7.9]
Zhao W, Zimmermann K, Zhou X, Zhou F, Fu M, Dernbach C, Scheele D, Weber B, Eckstein M, Hurlemann R, Kendrick KM, Becker B (2020) Impaired cognitive performance under psychosocial stress in cannabis-dependent men is associated with attenuated precuneus activity. Journal of Psychiatry & Neuroscience 44: 1 - 10 [IF 6.2]
Maier AM, Gieling C, Heinen-Ludwig L, Stefan V, Schultz J, Güntürkün O, Stoffel-Wagner B, Becker B, Hurlemann R, Scheele D (2020) Association of childhood maltreatment with interpersonal distance and social touch preferences in adulthood. The American Journal of Psychiatry 177: 37 - 46 [IF 18.1]
Kiebs M, Hurlemann R, Mielacher C (2020) Repetitive transkranielle Magnetstimulation in der Depressionsbehandlung. Internistische Praxis 63: 120 - 129 [IF n.a.] Reprints (2021) in: Tägliche Praxis 64: 497 - 506 & Paediatrische Praxis 96: 265 - 274 [IF n.a.]
Scheele D, Zimbal S, Feinstein JS, Delis A, Neumann C, Mielacher C, Philipsen A, Hurlemann R (2019) Treatment-resistant depression and ketamine response in a patient with bilateral amygdala damage. The American Journal of Psychiatry 176: 982 - 986 [IF 14.1]
Schmidt S, Hurlemann R, Schultz J, Wasserthal S, Kloss C, Maier W, Meyer-Lindenberg A, Hellmich M, Muthesius-Digon A, Wiesner PS, Klosterkötter J, Ruhrmann S (2019) Multimodal prevention of first psychotic episode through N-acetyl-L-cysteine and Integrated Preventive Psychological Intervention in individuals clinically at high risk for psychosis. Protocol of a randomised, placebo-controlled, parallel-group trial. Early Intervention in Psychiatry 13: 1404 - 1415 [IF 2.3]
Lardenoije R, Roubroeks JAY, Pishva E, Leber M, Wagner H, Iatrou A, Smith AR, Smith RG, Eijssen LMT, Kleineidam L, Kawalia A, Hoffmann P, Luck T, Riedel-Heller S, Jessen F, Maier W, Wagner M, Hurlemann R, Kenis G, Ali M, Del Sol A, Mastroeni D, Delvaux E, Coleman PD, Mill J, Rutten BPF, Lunnon K, Ramirez A, van den Hove DLA (2019) Alzheimer's disease-associated (hydroxy)methylomic changes in the brain and blood. Clinical Epigenetics 11: 164 [IF 5.0]
Bach DR, Hoffmann M, Finke C, Hurlemann R, Ploner C (2019) Disentangling hippocampal and amygdala contribution to human anxiety-like behavior. The Journal of Neuroscience 39: 8517 - 8526 [IF 5.7]
Kinfe TM, Buchfelder M, Chaudhry SR, Chakravarthy KV, Deer TR, Russo M, Georgius P, Hurlemann R, Rasheed M, Muhammad S, Yearwood TL. Leptin and associated mediators of immunometabolic signaling: Novel molecular outcome measures for neurostimulation to treat chronic pain. International Journal of Molecular Sciences 20: 4737 [IF 4.6]
Hurlemann R & Marsh N (2019) Unraveling the role of oxytocin in the motivational structure of conflict. Behavioral & Brain Sciences (BBS) 42: e126 [IF 17.3]
Zhou X, Zimmermann K, Xin F, Zhao W, Derckx R, Sassmannshausen A, Scheele D, Hurlemann R, Weber B, Kendrick KM, Becker B (2019) Cue-reactivity in the ventral striatum characterizes heavy cannabis use, whereas reactivity in the dorsal striatum mediates dependent use. Biological Psychiatry: Cognitive Neuroscience & Neuroimaging 4: 751 - 762 [IF 5.3]
Kiebs M, Hurlemann R, Fu CHY, Mutz J (2019) rTMS in non-treatment-resistant depression. The British Journal of Psychiatry 215: 445 - 446 [IF 7.9]
Schultz J, Willems T, Gädeke M, Chakkour G, Franke A, Weber B, Hurlemann R (2019) A human subcortical network underlying social avoidance revealed by risky economic choices. eLife 8: e45249 [IF 7.1]
Hasan MT, Althammer F, Silva da Gouveia M, Goyon S, Eliava M, Lefevre A, Kerspern D, Schimmer J, Raftogianni A, Wahis J, Knobloch-Bollmann HS, Tang Y, Liu X, Jain A, Chavant V, Goumon Y, Weislogel J-M, Hurlemann R, Herpertz SC, Pitzer C, Darbon P, Dogbevia GK, Bertocchi I, Larkum ME, Sprengel R, Bading H, Charlet A, Grinevich V (2019) A fear memory engram and its plasticity in the hypothalamic oxytocin system. Neuron 103: 133 - 146 [IF 14.4]
Kinfe TM, Asif M, Chakravarthy KV, Deer TR, Kramer JM, Yearwood TL, Hurlemann R, Hussain MS, Motameny S, Wagle P, Nürnberg P, Gravius S, Randau T, Gravius N, Chaudhry SR, Muhammad S (2019) Unilateral L4-dorsal root ganglion stimulation evokes pain relief in chronic neuropathic postsurgical knee pain and changes of inflammatory markers: part II whole transcriptome profiling. Journal of Translational Medicine 17: 205 [IF 4.1]
Coenen V, Bewernick B, Kayser S, Kilian H, Boström J, Greschus S, Hurlemann R, Klein M, Spanier S, Sajonz B, Urbach H, Schlaepfer TE (2019) Superolateral medial forebrain bundle deep brain stimulation in major depression – a gateway trial. Neuropsychopharmacology 44: 1224 - 1232 [IF 6.8]
Spengler FB, Scheele D, Kaiser S, Heinrichs M. Hurlemann R (2019) A protective mechanism against illusory perceptions is amygdala-dependent. The Journal of Neuroscience 39: 3301 - 3308 [IF 5.7]
Waytz A, Cacioppo JT, Hurlemann R, Castelli F, Adolphs R, Paul LK (2019) Anthropomorphizing without social cues requires the basolateral amygdala. Journal of Cognitive Neuroscience 31: 482 - 496 [IF 3.1]
Chakravarthy K, Xing F, Bruno K, Kent AR, Raza A, Hurlemann R, Kinfe TM (2019) A review of spinal and peripheral nneuromodulation and neuroinflammation: Lessons learned thus far and future prospects of biotype development. Neuromodulation: Technology at the Neural Interface 22: 235 - 243 [IF 4.0]
Mutz J, Vipulananthan V, Carter B, Hurlemann R, Fu CHY, Young AH (2019) Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis. BMJ - British Medical Journal 364: l1079 [IF 30.2]
Zimmermann K, Kendrick KM., Scheele D, Dau W, Banger M, Maier W, Weber B, Ma Y, Hurlemann R, Becker B (2019) Altered striatal reward processing in abstinent dependent cannabis users: social context matters. European Neuropsychopharmacology 29: 356 - 364 [3.9]
Luckhaus C, Juckel G, Hurlemann R (2018) Oxytocin in schizophrenia: Evidence for an etiological and therapeutic relevance of the social neuromodulator. Der Nervenarzt 90: 277 - 284 [IF 0.8]
Boström A, Scheele D, Stoffel-Wagner B, Hönig F, Chaudhry SR, Muhammad S, Hurlemann R, Krauss JK, Lendvai IS, Chakravarthy KV, Kinfe TM (2019) Saliva molecular inflammatory profiling in female migraine patients responsive to adjunctive cervical non-invasive vagus nerve stimulation: the MOXY Study. Journal of Translational Medicine 17: 53 [IF 4.1]
Kiebs M, Hurlemann R, Mutz J (2019) Cognitive effects of non-surgical brain stimulation for major depressive disorder: Protocol for a systematic review and meta-analysis. BMJ Open 9: e023796 [IF 2.5]
Eckstein M, Almeida de Minas AC, Scheele D, Kreuder AK, Hurlemann R, Grinevich V, Ditzen B (2019) Oxytocin for learning calm and safety. International Journal of Psychophysiology 136: 5 - 14 [IF 2.6]
Chaudhry SR, Lendvai IS, Muhammad S, Westhofen P, Kruppenbacher J, Scheef L, Boecker H, Scheele D, Hurlemann R, Kinfe TM (2019) Interictal assay of peripheral circulating inflammatory mediators in migraine patients under adjunctive cervical non-invasive vagus nerve stimulation: a proof-of-concept study. Brain Stimulation 12: 643 - 651 [IF 6.6]
Lefevre A, Hurlemann R, Grinevich V (2019) Imaging neuropeptide effects on human brain function. Cell & Tissue Research (CTR) 375: 279 - 286 [IF 4.0]
Kreuder AK, Wassermann L, Wollseifer M, Ditzen B, Eckstein M, Stoffel-Wagner B, Hennig J, Hurlemann R, Scheele D (2019) Oxytocin enhances the pain-relieving effects of social support in romantic couples. Human Brain Mapping 40: 242 - 251 [IF 4.4]
Kinfe TM & Hurlemann R (2019) Non-invasive and invasive brain stimulation concepts for the targeted treatment of schizophrenia symptom domains. Der Nervenarzt 90: 73 - 88 [IF 0.8]
Gravius N, Chaudhry SR, Muhammad S, Boström A, Gravius S, Randau T, Scheele D, Westhofen P, Kruppenbacher J, Stoffel-Wagner B, Maier C, Weidlich A, Yearwood TL, Chakravarthy KV, Kramer JM, Hurlemann R, Kinfe TM (2019) Selective L4 dorsal root ganglion stimulation evokes pain relief and changes of inflammatory markers: Profiling of saliva and serum molecular patterns. Neuromodulation: Technology at the Neural Interface 22: 44 - 52 [IF 4.0]
Maier A, Scheele D, Spengler F, Menba T, Mohr F, Güntürkün O, Stoffel-Wagner B, Kinfe T, Maier W, Khalsa S, Hurlemann R (2019) Oxytocin reduces a chemosensory-induced stress bias in social perception. Neuropsychopharmacology 44: 281 - 288 [IF 6.8]
Scheele D, Lieberz J, Patin A, Engels C, Schneider L, Stoffel-Wagner B, Becker B, Hurlemann R (2019) Trauma disclosure moderates the effects of oxytocin on intrusions and neural responses to fear. Psychotherapy & Psychosomatics 88: 61 - 63 [IF 14.9]
Hurlemann R, Scheele D, Kinfe TM, Berger R, Philipsen A, Voncken M, Kuypers KPC, Schruers K (2019) Increased temporal discounting in social anxiety disorder normalizes after oxytocin treatment. Psychotherapy & Psychosomatics 88: 55 - 57 [IF 14.9]
Zhou F, Zimmermann K, Xin F, Scheele D, Dau W, Banger M, Weber B, Hurlemann R, Kendrick KM, Becker B (2018) Shifted balance of dorsal versus ventral striatal communication with frontal reward and regulatory regions in cannabis dependent males. Human Brain Mapping 39: 5062 - 5073 [IF 4.6]
Kinfe TM & Hurlemann R (2018) Is molecular inflammatory profiling a useful tool for personalized brain stimulation in psychiatric disorders? Neuromodulation: Technology at the Neural Interface 21: 826 - 827 [IF 2.1]
Steffens M, Neumann C, Kasparbauer A.-M, Becker B., Weber B, Mehta M.A, Hurlemann R, Ettinger U (2018) Effects of ketamine on brain function during response inhibition. Psychopharmacology 235: 3559 - 3571 [IF 3.4]
Lendvai IS, Maier A, Scheele D, Hurlemann R, Kinfe TM (2018) Spotlight on cervical vagus nerve stimulation in patients with primary headache disorders: A Review. Journal of Pain Research 11: 1613 - 1625 [IF 2.2]
Geng Y, Zhao W, Zhou F, Ma X, Yao S, Hurlemann R, Kendrick KM (2018) Oxytocin enhancement of emotional empathy: generalization across cultures and effects on amygdala activity. Frontiers in Behavioral Neuroscience 12: 512 [IF 2.6]
Zimmermann K, Yao S, Heinz M, Zhou F, Dau W, Banger M, Weber B, Hurlemann R, Becker B (2018) Altered orbitofrontal activity and dorsal striatal connectivity during emotion processing in dependent marijuana users after 28 days of abstinence. Psychopharmacology 235: 849 - 859 [IF 3.4]
Schultz J & Hurlemann R (2018) Characterizing variations in perceptual decision-making. Behavioral & Brain Sciences (BBS) 41: e241 [IF 17.2]
Schultz J, Becker B, Preckel K, Seifert M, Mielacher C, Conrad R, Kleiman A, Maier W, Kendrick KM, Hurlemann R (2018) Improving therapy outcome prediction in major depression using multimodal functional neuroimaging - a pilot study. Personalized Medicine in Psychiatry 11 - 12: 7 - 15 [IF n.a.]
Schultz J, Wasserthal S, Kloss C, Schmidt S, Ruhrmann S, Hurlemann R (2018) Prävention einer ersten psychotischen Episode. Nervenheilkunde 5: 313 - 317 [IF n.a.]
Wasserthal S, Kloss C, Hurlemann R, Schultz J (2018) N-Acetylcystein (NAC) - eine neue Option zur frühen Bekämpfung von Schizophrenie. DNP - Der Neurologe & Psychiater 19: 28 - 32 [IF n.a.]
Hurlemann R & Kiebs M (2018) Innovative pharmakologische Strategien für die Behandlung von Angststörungen. NeuroTransmitter 29: 32 - 35 [IF n.a.]
Andari E, Hurlemann R, Young LJ (2018) A precision medicine approach to oxytocin trials. Current Topics in Behavioral Neuroscience 35: 559 - 590 [IF n.a.]
Ettinger U, Hurlemann R, Chan RCK (2018) Oxytocin and schizophrenia spectrum disorders. Current Topics in Behavioral Neuroscience 35: 515 - 527 [IF n.a.]
Patin A, Scheele D, Hurlemann R (2018) Oxytocin and interpersonal relationships. Current Topics in Behavioral Neuroscience 35: 389 - 420 [IF n.a.]
